NCT00010283
- Conditions
- Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Carcinoma, Ovarian Epithelial
Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.
539 public trials
64 recruiting studies
Carcinoma, Ovarian Epithelial trial results
NCT00003883
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- University of Washington Medical Center Seattle, Washington, United States
NCT00004157
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00014391
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00098800
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +19 more
- Locations
-
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
NCT00002901
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +54 more
- Locations
-
- Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
Completed
Women Surviving Ovarian Cancer
NCT00596349
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00490711
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bratislava, Slovakia
Terminated
A Phase 1 Study of Cellgram-DC in Patients With Advanced or Recurrent Epithelial Ovarian Cancer
NCT04614051
- Conditions
- Adnexal Diseases, Advanced Epithelial Ovarian Cancer, Carcinoma, +19 more
- Locations
-
- Asan medical center Seoul, South Korea